Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: Evidence of potent and long-lasting pituitary dopamine receptor stimulation

1985 ◽  
Vol 27 (6) ◽  
pp. 707-711 ◽  
Author(s):  
C. Ferrari ◽  
P. Rampini ◽  
A. Paracchi ◽  
M. Boghen ◽  
F. Mailland
Keyword(s):  
Growth Hormone ◽  
Dopamine Receptor ◽  
Serum Prolactin ◽  
Receptor Stimulation ◽  
Hormone Levels

Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects

1983 ◽  
Vol 34 (1) ◽  
pp. 74-78 ◽  
Author(s):  
Carlo Ferrari ◽  
Cristiano Barbieri ◽  
Roberto Caldara ◽  
Pietro Rampini ◽  
Alessandra Paracchi ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Serum Prolactin ◽  
Hormone Levels

THE EFFECT OF THE PROGESTOGEN ETHYNODIOL DIACETATE ON GLUCOSE, INSULIN, AND GROWTH HORMONE AFTER SIX MONTHS TREATMENT

1972 ◽  
Vol 70 (2) ◽  
pp. 373-384 ◽  
Author(s):  
W. N. Spellacy ◽  
W. C. Buhi ◽  
S. A. Birk
Keyword(s):  
Growth Hormone ◽  
Blood Glucose ◽  
Plasma Insulin ◽  
Tolerance Test ◽  
Metabolic Effects ◽  
Oral Glucose ◽  
Hormone Levels ◽  
Glucose Levels ◽  
Ethynodiol Diacetate ◽  
Tolerance Curve

ABSTRACT Seventy-one women were treated with a daily dose of 0.25 mg of the progestogen ethynodiol diacetate. They were all tested with a three-hour oral glucose tolerance test before beginning the steroid and then again during the sixth month of use. Measurements were made of blood glucose and plasma insulin and growth hormone levels. There was a significant elevation of the blood glucose levels after steroid treatment as well as a deterioration in the tolerance curve in 12.9% of the women. The plasma insulin values were also elevated after drug treatment whereas the fasting ambulatory growth hormone levels did not significantly change. There was a significant association between the changes in glucose and insulin levels and the subject's age, control weight, or weight gain during treatment. The importance of considering the metabolic effects of the progestogen component of oral contraceptives is stressed.

Growth hormone levels in diabetes. Correlation with the clinical control of the disease

Diabetes ◽  
1976 ◽  
Vol 25 (3) ◽  
pp. 167-172 ◽  
Author(s):  
R. Vigneri ◽  
S. Squatrito ◽  
V. Pezzino ◽  
S. Filetti ◽  
S. Branca ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Hormone Levels ◽  
Clinical Control
Sign in / Sign up

Export Citation Format

Share Document